The Untold Story of Psychotropic Drugging

I have the responsibility to be free.

The Untold Story of Psychotropic Drugging

Psychotropic drugs. It’s the story of big money-drugs that fuel a $330 billion psychiatric industry, without a single cure.

The cost in human terms is even greater-these drugs now kill an estimated 42,000 people every year.

And the death count keeps rising. Containing more than 175 interviews with lawyers, mental health experts, the families of victims and the survivors themselves, this riveting documentary rips the mask off psychotropic drugging and exposes a brutal but well-entrenched money-making machine.

Before these drugs were introduced in the market, people who had these conditions would not have been given any drugs at all.

So it is the branding of a disease and it is the branding of a drug for a treatment of a disease that did not exist before the industry made the disease.

In the last fifteen years, HMOs, insurers, pharmaceutical companies, hospital corporations, physicians, and other segments of the industry contributed $479 million to political campaigns-more than the energy industry ($315 million), commercial banks ($133 million), and big tobacco ($52 million). Critical Condition by Donald L. Bartlett and James B. Steele

The problem is not just pharmaceuticals and it’s not just the the American Medical Association, and the private insurers, Blue Cross/Blue Shield and so on. The whole system now is dominated by for-profit corporations. I think a lot of that growth in private sector lobbying over the years has come about because, in every industry, as the industries have become more competitive or more cutthroat in terms of their competition, every individual company has hired fleets of lobbyists to take on their competitors.

When you’ve got that many lobbyists and public relations professionals and lawyers swarming over the Hill for these corporations, they also can come together against the public. And the public’s voice can easily be drowned out. Robert Reich, economist, and Bill Clinton’s Secretary of Labor

The combined profits for the ten drug companies in the Fortune 500 ($35.9 billion) were more than the profits for all the other 490 businesses put together ($33.7 billion) [in 2002]. Over the past two decades the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centers, and the medical profession itself. Dr. Marcia Angell, former editor in chief of the New England Journal of Medicine